Waystar expands authorization automation to address healthcare providers' top 2025 investment priority
Waystar (Nasdaq: WAY) has launched Auth Accelerate, a new solution to automate the prior authorization process in healthcare. The innovation reduces submission times by 70% and achieves 85% auto-approval rates, addressing a critical industry challenge that providers have identified as their top investment priority for 2025.
The solution decreases average payer approval wait times by 75%, from over four days to one day or less. This addresses a significant healthcare burden, as a recent American Medical Association survey revealed that over 25% of physicians report prior authorizations leading to serious adverse patient events, while 78% note that delays cause patients to abandon care.
Prisma Health, serving 1.6 million patients annually, is among the first organizations to implement Auth Accelerate. The launch follows Waystar's recent recognition as Best in KLAS for Patient Access solutions and the introduction of Waystar AltitudeAI™, including AltitudeCreate™ for denied claims appeals.
Waystar (Nasdaq: WAY) ha lanciato Auth Accelerate, una nuova soluzione per automatizzare il processo di autorizzazione preventiva in ambito sanitario. Questa innovazione riduce i tempi di invio del 70% e raggiunge tassi di auto-approvazione del 85%, affrontando una sfida critica del settore che i fornitori hanno identificato come la loro principale priorità di investimento per il 2025.
La soluzione diminuisce i tempi di attesa per l'approvazione da parte dei pagatori in media del 75%, passando da oltre quattro giorni a un giorno o meno. Questo affronta un significativo onere nel settore sanitario, poiché un recente sondaggio dell'American Medical Association ha rivelato che oltre il 25% dei medici riporta che le autorizzazioni preventive portano a gravi eventi avversi per i pazienti, mentre il 78% nota che i ritardi causano l'abbandono delle cure da parte dei pazienti.
Prisma Health, che serve 1,6 milioni di pazienti all'anno, è tra le prime organizzazioni a implementare Auth Accelerate. Il lancio segue il recente riconoscimento di Waystar come Best in KLAS per le soluzioni di accesso dei pazienti e l'introduzione di Waystar AltitudeAI™, inclusa AltitudeCreate™ per i ricorsi sulle richieste negate.
Waystar (Nasdaq: WAY) ha lanzado Auth Accelerate, una nueva solución para automatizar el proceso de autorización previa en el ámbito de la salud. Esta innovación reduce los tiempos de envío en un 70% y alcanza tasas de auto-aprobación del 85%, abordando un desafío crítico de la industria que los proveedores han identificado como su principal prioridad de inversión para 2025.
La solución disminuye los tiempos de espera promedio para la aprobación de los pagadores en un 75%, pasando de más de cuatro días a un día o menos. Esto aborda una carga significativa en el cuidado de la salud, ya que una reciente encuesta de la American Medical Association reveló que más del 25% de los médicos informan que las autorizaciones previas conducen a eventos adversos graves para los pacientes, mientras que el 78% señala que los retrasos hacen que los pacientes abandonen la atención.
Prisma Health, que atiende a 1.6 millones de pacientes anualmente, se encuentra entre las primeras organizaciones en implementar Auth Accelerate. El lanzamiento sigue al reciente reconocimiento de Waystar como Best in KLAS por soluciones de acceso del paciente y la introducción de Waystar AltitudeAI™, incluida AltitudeCreate™ para apelaciones de reclamaciones denegadas.
Waystar (Nasdaq: WAY)는 의료 분야의 사전 승인 프로세스를 자동화하는 새로운 솔루션 Auth Accelerate를 출시했습니다. 이 혁신은 제출 시간을 70% 단축하고 85%의 자동 승인 비율을 달성하여, 공급자들이 2025년의 주요 투자 우선 사항으로 지목한 중요한 산업 과제를 해결합니다.
이 솔루션은 평균 지불자 승인 대기 시간을 75% 단축시켜, 4일 이상에서 1일 이하로 줄입니다. 이는 최근 미국 의사 협회 조사에 따르면 25% 이상의 의사가 사전 승인이 심각한 환자 사건으로 이어진다고 보고했으며, 78%는 지연으로 인해 환자들이 치료를 포기한다고 언급한 바와 같이, 의료 분야의 상당한 부담을 해결합니다.
연간 160만 명의 환자를 서비스하는 Prisma Health는 Auth Accelerate를 구현하는 첫 번째 조직 중 하나입니다. 이 출시는 Waystar가 환자 접근 솔루션 부문에서 Best in KLAS로 인정받은 것과 Waystar AltitudeAI™의 도입, 거부된 청구에 대한 항소를 위한 AltitudeCreate™를 포함한 것에 이어 진행됩니다.
Waystar (Nasdaq: WAY) a lancé Auth Accelerate, une nouvelle solution pour automatiser le processus d'autorisation préalable dans le domaine de la santé. Cette innovation réduit les délais de soumission de 70% et atteint des taux d'auto-approbation de 85%, répondant à un défi critique de l'industrie que les prestataires ont identifié comme leur principale priorité d'investissement pour 2025.
La solution réduit les temps d'attente moyens pour l'approbation des payeurs de 75%, passant de plus de quatre jours à un jour ou moins. Cela répond à un fardeau significatif dans le secteur de la santé, car une récente enquête de l'American Medical Association a révélé que plus de 25% des médecins signalent que les autorisations préalables entraînent des événements indésirables graves pour les patients, tandis que 78% notent que les retards amènent les patients à abandonner leurs soins.
Prisma Health, qui dessert 1,6 million de patients par an, est l'une des premières organisations à mettre en œuvre Auth Accelerate. Ce lancement fait suite à la récente reconnaissance de Waystar comme Best in KLAS pour les solutions d'accès aux patients et à l'introduction de Waystar AltitudeAI™, y compris AltitudeCreate™ pour les appels de demandes refusées.
Waystar (Nasdaq: WAY) hat Auth Accelerate eingeführt, eine neue Lösung zur Automatisierung des Genehmigungsprozesses im Gesundheitswesen. Die Innovation reduziert die Einreichungszeiten um 70% und erreicht 85% Auto-Zulassungsraten, was eine kritische Herausforderung in der Branche angeht, die von den Anbietern als ihre oberste Investitionspriorität für 2025 identifiziert wurde.
Die Lösung verringert die durchschnittlichen Wartezeiten auf Genehmigungen von Zahlenden um 75%, von über vier Tagen auf einen Tag oder weniger. Dies adressiert eine erhebliche Belastung im Gesundheitswesen, da eine aktuelle Umfrage der American Medical Association ergeben hat, dass über 25% der Ärzte berichten, dass vorherige Genehmigungen zu schwerwiegenden negativen Ereignissen bei Patienten führen, während 78% anmerken, dass Verzögerungen dazu führen, dass Patienten die Pflege abbrechen.
Prisma Health, das jährlich 1,6 Millionen Patienten betreut, gehört zu den ersten Organisationen, die Auth Accelerate implementieren. Der Start folgt der jüngsten Anerkennung von Waystar als Best in KLAS für Patienten-Zugangslösungen und der Einführung von Waystar AltitudeAI™, einschließlich AltitudeCreate™ für abgelehnte Leistungsanträge.
- 70% reduction in authorization submission times
- 85% auto-approval rates achieved
- 75% decrease in payer approval wait times
- Named Best in KLAS for Patient Access solutions
- Launch of new AI capabilities with AltitudeAI
- None.
Insights
Waystar's latest product launch strategically aligns with healthcare providers' top revenue cycle investment priority for 2025. Auth Accelerate addresses a critical market pain point—prior authorizations—which currently requires up to 24 minutes per submission across tens of millions of annual authorizations industry-wide.
The solution's demonstrated metrics are compelling from a business perspective:
The early implementation by Prisma Health, serving 1.6 million patients annually, provides Waystar with a significant reference customer that could accelerate adoption. This launch builds on Waystar's broader innovation strategy, following their recent Best in KLAS recognition and AltitudeAI platform introduction.
For Waystar investors, this represents potential revenue growth opportunity in a high-demand segment where providers have already prioritized budget allocation. The recurring SaaS revenue model typical for these solutions could strengthen Waystar's long-term revenue stability while addressing a persistent healthcare administrative challenge.
The administrative burden of prior authorizations represents one of healthcare's most persistent operational challenges. Waystar's Auth Accelerate tackles this issue at a systemic level by automating the entire submission workflow rather than just portions of it.
From an operations perspective, the
The
Prisma Health's implementation provides validation from a large-scale health system with complex authorization needs. For health systems evaluating revenue cycle investments, Waystar's innovation addresses both financial performance (through reduced administrative costs) and clinical care delivery (through faster treatment approvals)—a compelling dual value proposition in today's margin-pressured healthcare environment.
Latest software innovation automates every step of the authorization submission process, reducing time by
Prior authorizations pose significant challenges across the healthcare spectrum. In response, providers have made automation for patient access, including prior authorizations, their top investment revenue cycle priority for 2025, according to a recent third-party survey. Securing payer approval requires navigating complex rules and continuous status checks, consuming up to 24 minutes per authorization. With tens of millions of prior authorizations occurring each year, this labor-intensive process contributes to one of healthcare's top administrative burdens. A recent American Medical Association survey found that more than one in four physicians say prior authorization has led to a serious adverse event for a patient in their care, while
Waystar Auth Accelerate overhauls this traditionally time-consuming workflow by automating every step of the authorization submission process. Based on data from implemented clients, this innovation reduces submission times by
"Providers consistently identify prior authorization as a top challenge, noting its strain on resources and impact on patient care," said Matt Hawkins, Chief Executive Officer of Waystar. "With advanced automation, Waystar Auth Accelerate streamlines this process, allowing providers to focus more on patients instead of administrative tasks. We remain committed to delivering meaningful innovations that help providers get paid faster and more accurately while ensuring patients receive a modern, transparent, and consumer-friendly financial experience."
Prisma Health,
"Prior authorizations are one of our biggest administrative challenges," said Patrick Griffin, Executive Director of Revenue Cycle for Prisma Health. "By collaborating with industry partners on innovative processes that deliver high-impact solutions, we are able to make a significant difference for our organization and help provide better care for our patients."
Providers increasingly rely on Waystar's innovative cloud-based software platform to drive operational efficiency, boost financial performance, and overcome critical administrative challenges like prior authorizations. In January, Waystar's Patient Access solutions were named Best in KLAS. Last month, the company also announced the launch of Waystar AltitudeAI™, a comprehensive set of AI capabilities for providers, including AltitudeCreate™, a new generative AI innovation designed to help appeal denied claims.
About Waystar
Waystar's mission-critical software is purpose-built to simplify healthcare payments so providers can prioritize patient care and optimize their financial performance. Waystar serves approximately 30,000 clients, representing over 1 million distinct providers, including 16 of 20 institutions on the
Media Contact
Kristin Lee
kristin.lee@waystar.com
Investor Contact
Sandy Draper
investors@waystar.com
502-238-9511
View original content to download multimedia:https://www.prnewswire.com/news-releases/waystar-expands-authorization-automation-to-address-healthcare-providers-top-2025-investment-priority-302388171.html
SOURCE Waystar
FAQ
What are the key performance metrics of Waystar's (WAY) new Auth Accelerate solution?
How does Waystar's (WAY) Auth Accelerate address healthcare provider challenges in 2025?
What impact do prior authorization delays have on patient care according to Waystar's (WAY) announcement?
Which major healthcare provider has implemented Waystar's (WAY) Auth Accelerate solution?
